Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Economic Impact of Reducing Hospital Admissions for Patients Presenting to the Emergency Department With Worsening Heart Failure: An Adaptive Clinical Trial of Furoscix Infusor

X
Trial Profile

Economic Impact of Reducing Hospital Admissions for Patients Presenting to the Emergency Department With Worsening Heart Failure: An Adaptive Clinical Trial of Furoscix Infusor

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Furosemide (Primary) ; Furosemide
  • Indications Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms FREEDOM-HF
  • Sponsors scPharmaceuticals
  • Most Recent Events

    • 10 Aug 2023 According to scPharmaceuticals Media Release, the company announced that results from the FREEDOM-HF study have been accepted for publication in the peer-reviewed journal Future Cardiology.
    • 10 May 2023 According to a scPharmaceuticals media release, data from this study were presented at the Technology and Heart Failure Therapeutics Conference 2023.
    • 22 Mar 2023 According to a scPharmaceuticals media release, data from this study will be presented at the Technology and Heart Failure Therapeutics Conference, March 20-22, 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top